High-dose intensity regimens with epirubicin in ovarian cancer

Semin Oncol. 1994 Feb;21(1 Suppl 1):17-22.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Epirubicin / administration & dosage*
  • Epirubicin / adverse effects
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
  • Humans
  • Ovarian Neoplasms / drug therapy*

Substances

  • Epirubicin
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Cisplatin